Tobacco use is not associated with increased risk of recurrent reflux 5 years after laparoscopic anti-reflux surgery

  • PDF / 818,499 Bytes
  • 8 Pages / 595.276 x 790.866 pts Page_size
  • 76 Downloads / 168 Views

DOWNLOAD

REPORT


and Other Interventional Techniques

2020 SAGES ORAL

Tobacco use is not associated with increased risk of recurrent reflux 5 years after laparoscopic anti‑reflux surgery Vivian L. Wang1 · Anahita D. Jalilvand1 · Anand Gupta1 · Jennwood Chen1 · Chaitanya Vadlamudi1 · Kyle A. Perry1,2  Received: 4 April 2020 / Accepted: 27 August 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020

Abstract Introduction  Tobacco use worsens gastrointestinal reflux disease (GERD). Smoking cessation improves GERD symptoms, but its impact on the efficacy of laparoscopic anti-reflux surgery (LARS) is unclear. In this retrospective cohort study, we hypothesized that non-smokers would demonstrate greater long-term improvements in disease-specific quality of life than active smokers. Methods  Data were maintained in an IRB-approved prospective database, and patients were stratified according to tobacco use. Postoperative follow-up occurred in clinic and long-term follow-up via telephone interview. Outcomes measured were gastroesophageal health-related quality of life (GERD-HRQL) and GERD symptom scale (GERSS) scores, proton pump inhibitor (PPI) cessation, and satisfaction with surgery. Results  Two hundred and thirty-five patients underwent primary LARS, and 31 (13%) were active smokers with 18 median pack-years [10–30]. Baseline PPI use (96% vs. 94%, p = 0.64), presence of a hiatal hernia (79% vs. 68%, p = 0.13), esophagitis (28% vs. 45%, p = 0.13), and DeMeester score (41.9 vs. 33.6, p = 0.47) were similar. Baseline GERD-HRQL and GERSS scores and their post-surgical decreases were also similar between groups. PPI cessation was achieved in 92% of non-smokers and 94% of smokers (p = 0.79), and GERD-HRQL scores decreased to 4 [1–7] and 5 [0–12], respectively (p = 0.53). After 59 [25–74] months, GERD-HRQL scores were 5 [2–11] and 2 [0–13] (p = 0.61) and PPI cessation was maintained in 69% and 79% of patients (p = 0.59). Satisfaction with surgery was similar between smokers and non-smokers (88% vs. 87%, p = 0.85). Female gender was significantly associated with increased improvements in GERD-HRQL (p